What happened. Shares of Tonix Pharmaceuticals ( TNXP -6.93% ) were crashing 28.3% lower as of 10:24 a.m. EDT on Monday. The big decline came after Tonix announced on Friday following the market close that it is halting enrollment in a late-stage clinical study evaluating TNX-102 SL in treating fibromyalgia.
Similarly What was the highest price of TNXP? The latest closing stock price for Tonix Pharmaceuticals Holding as of April 12, 2022 is 0.18. The all-time high Tonix Pharmaceuticals Holding stock closing price was 30000.00 on May 10, 2012. The Tonix Pharmaceuticals Holding 52-week high stock price is 1.42, which is 688.9% above the current share price.
Why was TNXP stock so high? A big regulatory win was reaping huge prizes for Tonix Pharmaceuticals ( TNXP -1.10% ) on Thursday. Following a new nod from the Food and Drug Administration (FDA) for one of its leading pipeline drugs, the biotech’s shares went on a quick trip skyward, rising 33% in price on the day.
Additionally, Will Tonix stock go up?
The Tonix Pharmaceuticals Holding Corp. stock price gained 4.63% on the last trading day (Monday, 4th Apr 2022), rising from $0.22 to $0.23.
…
Predicted Opening Price for Tonix Pharmaceuticals Holding Corp. of Tuesday, April 5, 2022.
| Fair opening price April 5, 2022 | Current price |
|---|---|
| $0.23 | $0.23 (Overvalued) |
Is TNXP worth buying?
Tonix Pharmaceuticals has received a consensus rating of Buy.
What is the future of TNXP? On average, analysts forecast that TNXP’s EPS will be -$0.20 for 2022, with the lowest EPS forecast at -$0.20, and the highest EPS forecast at -$0.20. On average, analysts forecast that TNXP’s EPS will be -$0.20 for 2023, with the lowest EPS forecast at -$0.20, and the highest EPS forecast at -$0.20.
Is TNXP going to reverse split? (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that it will effect a 1-for-10 reverse stock split of its outstanding common stock. This will be effective for trading purposes as of the commencement of trading on November 1, 2019.
Did TNXP reverse split? 31, 2019 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that it will effect a 1-for-10 reverse stock split of its outstanding common stock.
Will Biol stock go up?
During the day the stock fluctuated 3.81% from a day low at $0.30 to a day high of $0.31. The price has fallen in 7 of the last 10 days and is down by -13.17% for this period.
…
Predicted Opening Price for Biolase of Monday, April 18, 2022.
| Fair opening price April 18, 2022 | Current price |
|---|---|
| $0.31 | $0.31 (Undervalued) |
Will TXMD stock go up? The average THERAPEUTICSMD stock price prediction forecasts a potential upside of 762.07% from the current TXMD share price of $0.29.
Why is OCGN stock down?
Ocugen’s OCGN stock declined 3.8% on Tuesday after the FDA placed a clinical hold on a phase II/III immuno-bridging and broadening clinical study on its COVID-19 vaccine, Covaxin.
What TNX 102? TNX-102 SL is a patented sublingual tablet formulation of cyclobenzaprine hydrochloride which provides rapid transmucosal absorption and reduced production of a long half-life active metabolite, norcyclobenzaprine, due to bypass of first-pass hepatic metabolism.
Should I hold BIOL?
3 Wall Street analysts have issued « buy, » « hold, » and « sell » ratings for BIOLASE in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should « buy » BIOLASE stock.
Is BIOL stock a good investment?
BIOLASE Stock Forecast FAQ
Is BIOLASE Stock a good buy in 2022, according to Wall Street analysts? The consensus among 1 Wall Street analyst covering (NASDAQ: BIOL) stock is to Buy BIOL stock.
Is BIOL a good investment? BIOLASE, Inc.
So if you are looking for a fast growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider BIOL. Not only does it have double-digit earnings growth prospects, but its impressive Zacks Rank suggests that analysts believe better days are ahead for BIOL as well.
Is TXMD buy or sell? A yield of 8.57% also means 8.57 cents of earnings for $1 of investment.
…
Momentum Scorecard. More Info.
| Zacks Rank | Definition | Annualized Return |
|---|---|---|
| 1 | Strong Buy | 24.93% |
| 2 | Buy | 18.44% |
| 3 | Hold | 9.99% |
| 4 | Sell | 5.61% |
Is TXMD undervalued?
Simply put TXMD is grossly undervalued right now because TXMD trades at 3.5X FY2020’s consensus revenue estimate whereas TXMD peers trade at 10X.
Is TXMD a good company? TXMD has an overall D rating, which equates to Sell in our proprietary POWR Ratings system. The POWR ratings are calculated by considering 118 distinct factors, with each factor weighted to an optimal degree. Our proprietary rating system also evaluates each stock based on eight distinct categories.
Is OCGN stock a buy?
During the day the stock fluctuated 9.03% from a day low at $2.77 to a day high of $3.02. The price has fallen in 8 of the last 10 days and is down by -11.87% for this period.
…
Predicted Opening Price for Ocugen Inc of Thursday, April 14, 2022.
| Fair opening price April 14, 2022 | Current price |
|---|---|
| $2.92 | $2.97 (Overvalued) |
Is OCGN a good stock to buy? Is OCUGEN Stock a good buy in 2022, according to Wall Street analysts? The consensus among 3 Wall Street analysts covering (NASDAQ: OCGN) stock is to Hold OCGN stock.
Is OCGN a buy or sell?
Ocugen has received a consensus rating of Hold. The company’s average rating score is 2.40, and is based on 2 buy ratings, 3 hold ratings, and no sell ratings.
Is Wisa a good buy? Its Value Score of F indicates it would be a bad pick for value investors. The financial health and growth prospects of WISA, demonstrate its potential to underperform the market. It currently has a Growth Score of B.
Is Globalstar a buy or sell? For example, a stock trading at $35 with earnings of $3 would have an earnings yield of 0.0857 or 8.57%. A yield of 8.57% also means 8.57 cents of earnings for $1 of investment.
…
Momentum Scorecard. More Info.
| Zacks Rank | Definition | Annualized Return |
|---|---|---|
| 1 | Strong Buy | 24.93% |
| 2 | Buy | 18.44% |
| 3 | Hold | 9.99% |
| 4 | Sell | 5.61% |
Is biolase going to be delisted?
At just 47 cents a share, BIOL stock is in danger of being delisted by the Nasdaq, which requires companies to maintain a minimum share price of $1 to remain on the exchange. However, in a news release, BIOLASE announced that it has been granted a 180-day extension to regain compliance with this requirement.
